We further determined the proportion of CD133+ cells every 24 h for 5 days after treatment of pancreatic cancer cells with low concentrations of metformin and produced growth curves for both CD133+ and CD133– cells. This evidence concerns the gene PROM1 and pancreatic neoplasm.